Publications by the researcher in collaboration with Juan Sanchis Forés (49)

2025

  1. Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial

    Heart

  2. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 319-326

  3. Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako)

    Revista Espanola de Cardiologia

2024

  1. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

  2. Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako)

    Revista Española de Cardiología (English Edition)

  3. Routine invasive strategy and frailty burden in non-ST-segment elevation acute myocardial infarction

    Journal of Geriatric Cardiology, Vol. 21, Núm. 10, pp. 954-961

2023

  1. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  2. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  2. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study

    Journal of Geriatric Cardiology, Vol. 19, Núm. 5, pp. 354-366

  3. Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826

2021

  1. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  2. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  5. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  6. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Beneficio del tratamiento invasivo en ancianos con comorbilidades y síndrome coronario agudo sin elevación del ST

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 315-315

  2. FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 21, Núm. 5, pp. 683-687.e1

  3. Impact of Diabetes Mellitus and Frailty on Long-Term Outcomes in Elderly Patients with Acute Coronary Syndromes

    Journal of Nutrition, Health and Aging, Vol. 24, Núm. 7, pp. 723-729